Co-encapsulated liposomal formulations of tubacin and erlotinib.HCl: a comprehensive stability strategy
Cindy Schelker, Catia Monteiro, Gerrit Borchard, Patrycja M. Nowak-Sliwinska
This study develops a stable liposomal formulation of tubacin and erlotinib.HCl using freeze-drying and cryoprotectants to maintain drug encapsulation and particle size.
bioRxiv · Oct 8, 2025 · PreprintCancer Biology